eversyn GmbH is an innovative biotechnology startup based in Magdeburg, Saxony-Anhalt, Germany. Founded in 2022, the company is a spin-off from the Max Planck Institute for Dynamics of Complex Technical Systems. eversyn specializes in developing cutting-edge technologies for the production of nucleotide sugars and oligosaccharides, with applications in nutrition and pharmaceuticals.

The company was established by a team of former Max Planck scientists and business professionals, combining deep scientific expertise with entrepreneurial acumen. Recently, eversyn secured €1.6 million in seed funding.